Biologic therapies, which have transformed the treatment of rheumatoid arthritis (RA) in the 21stCentury, have the potential to modulate immune responses and thus are associated with a risk of infection, as well as other adverse events. This Review summarizes the available safety data for all such agents approved for the treatment of RA, to assist clinicians in weighing potential risks and therapeutic benefits.
- Robert S. Woodrick
- Eric M. Ruderman